TWI800922B - Short peptide, hydrolyzate containing the short peptide and its use for preventing or/and treating diseases related to nerve damage - Google Patents
Short peptide, hydrolyzate containing the short peptide and its use for preventing or/and treating diseases related to nerve damage Download PDFInfo
- Publication number
- TWI800922B TWI800922B TW110134263A TW110134263A TWI800922B TW I800922 B TWI800922 B TW I800922B TW 110134263 A TW110134263 A TW 110134263A TW 110134263 A TW110134263 A TW 110134263A TW I800922 B TWI800922 B TW I800922B
- Authority
- TW
- Taiwan
- Prior art keywords
- short peptide
- preventing
- treating diseases
- diseases related
- nerve damage
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW110134263A TWI800922B (en) | 2021-09-14 | 2021-09-14 | Short peptide, hydrolyzate containing the short peptide and its use for preventing or/and treating diseases related to nerve damage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW110134263A TWI800922B (en) | 2021-09-14 | 2021-09-14 | Short peptide, hydrolyzate containing the short peptide and its use for preventing or/and treating diseases related to nerve damage |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202311280A TW202311280A (en) | 2023-03-16 |
TWI800922B true TWI800922B (en) | 2023-05-01 |
Family
ID=86690499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW110134263A TWI800922B (en) | 2021-09-14 | 2021-09-14 | Short peptide, hydrolyzate containing the short peptide and its use for preventing or/and treating diseases related to nerve damage |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI800922B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080305212A1 (en) * | 2007-04-16 | 2008-12-11 | Solae, Llc | Protein Hydrolysate Compositions Having Improved Sensory Characteristics and Physical Properties |
US20120087862A1 (en) * | 2006-08-09 | 2012-04-12 | Homestead Clinical Corporation | Organ-specific proteins and methods of their use |
US20170183386A1 (en) * | 2015-07-16 | 2017-06-29 | Nuritas Limited | Peptides, and uses thereof |
-
2021
- 2021-09-14 TW TW110134263A patent/TWI800922B/en active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120087862A1 (en) * | 2006-08-09 | 2012-04-12 | Homestead Clinical Corporation | Organ-specific proteins and methods of their use |
US20080305212A1 (en) * | 2007-04-16 | 2008-12-11 | Solae, Llc | Protein Hydrolysate Compositions Having Improved Sensory Characteristics and Physical Properties |
US20170183386A1 (en) * | 2015-07-16 | 2017-06-29 | Nuritas Limited | Peptides, and uses thereof |
Non-Patent Citations (2)
Title |
---|
專書 R.E. Aluko, Food protein-derived peptides: Production, isolation, and purification Proteins in Food Processing (Second Edition) Woodhead Publishing 2018;期刊 Chibuike C. Udenigwe and Rotimi E. Aluko, "Food Protein-Derived Bioactive Peptides: Production, Processing, and Potential Health Benefits" J Food Sci., Vol 77,No.1, Jan 2012, pages R11-24 * |
期刊 Chibuike C. Udenigwe and Rotimi E. Aluko, "Food Protein-Derived Bioactive Peptides: Production, Processing, and Potential Health Benefits" J Food Sci., Vol 77,No.1, Jan 2012, pages R11-24 |
Also Published As
Publication number | Publication date |
---|---|
TW202311280A (en) | 2023-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL280358A (en) | Novel autotac chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprosing the same | |
WO2015175986A3 (en) | Keratin treatment formulations and methods | |
EA201500802A1 (en) | METHODS OF PREVENTION AND / OR TREATMENT OF CARDIOMYOPATHY AND ELIMINATION OF CARDIOMYOPATHY SYMPTOMS, PHARMACEUTICAL COMPOSITION, VECTORS | |
JOP20200033A1 (en) | Amino acid compositions for the treatment of liver disease | |
WO2017151860A8 (en) | Human kynureninase enzyme variants having improved pharmacological properties | |
EA202190708A1 (en) | EXPRESSION MODULATORS PNPLA3 | |
WO2016131000A3 (en) | Tolerance therapeutic for treating polypeptide induced allergy | |
MX2021013354A (en) | Methods of treating and/or preventing actinic keratosis. | |
IL282423A (en) | Modified cas9 protein, and use thereof | |
EP3826684A4 (en) | Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same | |
MX2020009532A (en) | Modified oligonucleotides for use in treatment of tauopathies. | |
UY38352A (en) | INTEGRIN INHIBITORS ALFAVBETA6 | |
PH12021550122A1 (en) | Solubilized apyrases, methods and use | |
EA202092487A1 (en) | HUMAN KINURENINASE ENZYMES AND THEIR APPLICATION | |
CO6592047A2 (en) | Topical ophthalmic peptide formulation | |
WO2018175749A3 (en) | Lrp1 binding agents and uses thereof | |
BR112019003816A2 (en) | hair rinse treatment composition, method for treating chemically damaged hair and use of a composition | |
EP3639839A4 (en) | Peptide with antidepressant activity and therapeutic effect against alzheimer's disease | |
EP3632433A4 (en) | Novel glutaminyl cyclase inhibitors and the use thereof in treatment of various diseases | |
WO2018094023A3 (en) | Cyclic dipeptides and wound healing | |
EP3843690A4 (en) | Personal care spray compositions and methods comprising trans-1-chloro-3,3,3-trifluoropropene | |
TWI800922B (en) | Short peptide, hydrolyzate containing the short peptide and its use for preventing or/and treating diseases related to nerve damage | |
PL3937948T3 (en) | Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases | |
JP2018536642A5 (en) | Medical compositions and medical hydrogels for use in facet joint replacement and / or regeneration and / or for use in the prevention and / or treatment of facet joint diseases | |
EP4021906A4 (en) | N-(2-aminophenyl)-prop-2-enamide derivatives, and uses thereof in the treatment of cancer |